The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.

While breast and cervical cancers often dominate women's health discussions, several rare cancers deserve equal attention.

Medically reviewed by Renita White, MD Perimenopause is the transition period when the female body starts to shift from ...

Background: Tamoxifen is standard adjuvant treatment for postmenopausal women with hormone-receptor-positive breast cancer. We assessed the benefit of adding chemotherapy to adjuvant tamoxifen and ...